ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA A
Country: Canada
Language: English
Source: Health Canada
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
DEXTROSE; SODIUM CITRATE; CITRIC ACID
Available from:
FRESENIUS KABI AG
ATC code:
V07AC
INN (International Name):
BLOOD TRANSFUSION, AUXILIARY PRODUCTS
Dosage:
2.45G; 2.2G; 730MG
Pharmaceutical form:
SOLUTION
Composition:
DEXTROSE 2.45G; SODIUM CITRATE 2.2G; CITRIC ACID 730MG
Administration route:
0-UNASSIGNED
Units in package:
500ML/1000ML
Prescription type:
Ethical
Therapeutic area:
MISCELLANEOUS ANTICOAGULANTS
Product summary:
Active ingredient group (AIG) number: 0300464001; AHFS:
Authorization status:
APPROVED
Authorization date:
2008-04-04
